Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease by Ismail, Yazan et al.
Investigation of the Enteric Pathogenic Potential of Oral
Campylobacter concisus Strains Isolated from Patients
with Inflammatory Bowel Disease
Yazan Ismail
1., Vikneswari Mahendran
1., Sophie Octavia
1, Andrew S. Day
2,3,4, Stephen M. Riordan
5,7,
Michael C. Grimm
6, Ruiting Lan
1, Daniel Lemberg
2, Thi Anh Tuyet Tran
1, Li Zhang
1*
1The School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia, 2Department of Gastroenterology, Sydney Children’s
Hospital, Sydney, Australia, 3School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia, 4Department of Paediatrics, University of Otago,
Christchurch, New Zealand, 5Gastrointestinal and Liver Unit, The Prince of Wales Hospital, Sydney, Australia, 6St. George Clinical School, University of New South Wales,
Sydney, Australia, 7Faculty of Medicine, University of New South Wales, Sydney, Australia
Abstract
Background: Campylobacter concisus, a bacterium colonizing the human oral cavity, has been shown to be associated with
inflammatory bowel disease (IBD). This study investigated if patients with IBD are colonized with specific oral C. concisus
strains that have potential to cause enteric diseases.
Methodology: Seventy oral and enteric C. concisus isolates obtained from eight patients with IBD and six controls were
examined for housekeeping genes by multilocus sequence typing (MLST), Caco2 cell invasion by gentamicin-protection-
assay, protein analysis by mass spectrometry and SDS-PAGE, and morphology by scanning electron microscopy. The whole
genome sequenced C. concisus strain 13826 which was isolated from an individual with bloody diarrhea was included in
MLST analysis.
Principal Findings: MLST analysis showed that 87.5% of individuals whose C. concisus belonged to Cluster I had
inflammatory enteric diseases (six IBD and one with bloody diarrhea), which was significantly higher than that in the
remaining individuals (28.6%) (P,0.05). Enteric invasive C. concisus (EICC) oral strain was detected in 50% of patients with
IBD and none of the controls. All EICC strains were in Cluster 1. The C. concisus strain colonizing intestinal tissues of patient
No. 1 was closely related to the oral C. concisus strain from patient No. 6 and had gene recombination with the patient’s
own oral C. concisus. The oral and intestinal C. concisus strains of patient No. 3 were the same strain. Some individuals were
colonized with multiple oral C. concisus strains that have undergone natural recombination.
Conclusions: This study provides the first evidence that patients with IBD are colonized with specific oral C. concisus strains,
with some being EICC strains. C. concisus colonizing intestinal tissues of patients with IBD at least in some instances results
from an endogenous colonization of the patient’s oral C. concisus and that C. concisus strains undergo natural
recombination.
Citation: Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, et al. (2012) Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus
Strains Isolated from Patients with Inflammatory Bowel Disease. PLoS ONE 7(5): e38217. doi:10.1371/journal.pone.0038217
Editor: Stefan Bereswill, Charite ´-University Medicine Berlin, Germany
Received December 19, 2011; Accepted May 1, 2012; Published May 30, 2012
Copyright:  2012 Ismail et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant no: IBD0273-R) and a research grant awarded to Dr Li
Zhang from the Faculty of Science, University of New South Wales (FRG2011). Yazan Ismail is supported by a PhD scholarship from Al-Balaq’ Applied University,
Jordan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: L.Zhang@unsw.edu.au
. These authors contributed equally to this work.
Introduction
Campylobacter oncisus is a Gram-negative bacterium with a curved
shape and a polar flagellum, which was first isolated from human
gingival plaques in 1981 [1]. C. concisus is a fastidious bacterium,
requiring hydrogen enriched microaerobic conditions for growth
[2,3].
Recently, C. concisus has been shown to be associated with
inflammatory bowel disease (IBD). IBD is a chronic inflammatory
disorder of the gastrointestinal tract; the two major forms of IBD
are Crohn’s disease (CD) and ulcerative colitis (UC) [4,5]. The
aetiology of IBD is unknown. Studies have shown that multiple
factors including genetic factors, environmental factors and
intestinal microflora are involved in the development of IBD
[4,5]. Despite strong evidence showing that the intestinal
microbiota plays a key role in the pathogenesis of IBD, the exact
causative or triggering agent still remains unknown [6,7,8].
A significantly higher prevalence of C. concisus in intestinal
biopsies and fecal samples of patients with IBD as compared with
controls were reported by a number of research groups
[9,10,11,12]. Using in vitro cell culture models, C. concisus was
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intestinal epithelial production of IL-8 and apoptosis [13,14,15].
Some C. concisus strains cultured from intestinal biopsies of patients
with IBD and diarrheal stool samples were shown to be invasive to
Caco2 cells [14]. The presence of bacterial virulence factors such
as phospholipase A2 and a cytolethal distending toxin (CDT)-like
toxin in some C. concisus strains has been reported [16,17].
C. concisus is a commensal bacterium of the human oral cavity.
Zhang et al isolated C. concisus from 75% of saliva samples obtained
from healthy individuals aged 3 to 60 years old and detected
C. concisus by PCR in 95% of these samples [18]. The prevalence
of C. concisus in the oral cavity of patients with IBD and healthy
controls was not statistically different [18]. Furthermore, this study
noted some bacterial protein banding similarities between a
C. concisus strain colonizing the oral cavity and the C. concisus strain
colonizing the intestinal tissues of a patient with IBD and proposed
that specific oral C. concisus strains are involved in human IBD
[18].
Currently, whether patients with IBD are colonized with
specific oral C. concisus strains is not known. It is also not clear
whether oral C. concisus strains have enteric pathogenic potential
and whether C. concisus colonizing intestinal tissues of a given
patient with IBD results from an endogenous colonization of the
patient’s own oral C. concisus. To investigate these issues, we
compared the housekeeping genes and protein profiles of oral
C. concisus isolated from patients with IBD and controls, as well as
C. concisus isolated from intestinal biopsies of patients with IBD. In
addition, we examined the invasiveness of oral C. concisus isolates to
Caco2 cells and identified a number of bacterial proteins that may
be important to C. concisus invasion of Caco2 cells.
Results
Analysis of Housekeeping Genes of Oral and Enteric
C. Concisus Isolated from Patients with IBD and Controls
by Multilocus Sequence Typing
Six housekeeping genes amplified from 70 C. concisus isolates,
which were obtained from eight patients with IBD and six controls
(details of these C. concisus isolates were described in Materials and
Methods section), were analysed by multilocus sequence typing
(MLST). The six housekeeping genes amplified were aspA
(aspartase A), glnA (glutamine synthetase), tkt (transkelotase), asd
(aspartate semialdehyde dehydrogenase), atpA (ATP synthase alpha
subunit) and pgi (glucose-6-isomerase). MLST analysis was based
on the sequences of six housekeeping genes with a total of
2,561 bp from each isolate analysed. The sequence types (ST) and
allelic profiles of C. concisus isolates analysed are shown in Table 1.
The polymorphic nucleotides were submitted as supplementary
data (Figure S1). The criteria to define strains and variants were
described in the Materials and Methods section.
MLST Analysis of Oral C. Concisus Isolated from Patients
with IBD and Controls
Among the 21 oral C. concisus isolates (P1CDO1-P1CDO21)
obtained from patient No. 1, five sequence types (ST1- ST5) of
C. concisus were identified (Table 1). ST1 included 16 isolates
(P1CDO1, P1CDO5-O12, P1CDO14-O17 and P1CDO19-O21).
ST2 included two isolates (P1CDO3 and P1CDO18). ST3, ST4
and ST5 each contained a single isolate (P1CDO4, P1CDO13
and P1CDO2) respectively. ST1 and ST2 differed in all six
housekeeping genes (showing different allelic numbers at all six
housekeeping genes), representing two different strains (Table 1).
ST3 (P1CDO4) had four housekeeping genes (asd, atpA, glnA, and
pgi) identical to ST1, aspA gene identical to ST2 and tkt gene
identical to ST5, suggesting that this isolate resulted from genomic
recombination between ST1, ST2 and ST5 (Table 1). ST4
(P1CDO13) had five housekeeping genes identical to ST1 and its
asd gene was different from the patient’s oral C. concisus isolates,
suggesting that ST4 is a recombinant of ST1 and an unsampled
C. concisus isolate (Table 1). ST5 had housekeeping genes identical
to ST1 except for one nucleotide mutation in tkt gene, suggesting
that ST5 is a mutational variant of ST1 (Table 1 and Figure S1).
Thus, two oral strains (ST1 and ST2), two recombinant variants
(ST3 and ST4) and one mutational variant (ST5) were identified
from patient 1.
Five STs (ST7-ST11) were identified in oral C. concisus isolates
obtained from patient No. 2 (Table 1). ST7 contained two isolates
(P2CDO1 and P2CDO4). ST8 contained two isolates (P2CDO3
and P2CDO7). ST7 and ST8 differed at all six housekeeping
genes, representing two different strains (Table 1). ST9 contained
one isolate (P2CDO5), which had five housekeeping genes
identical to ST7 and tkt gene identical to ST8, suggesting that
ST9 is a recombinant of ST7 and ST8 (Table 1). ST10 contained
one isolate (P2CDO2), which had five housekeeping genes
identical to ST8 and aspA gene identical to ST7, suggesting that
ST10 is also a recombinant of ST7 and ST8 (Table 1). ST11
(P2CDO6) had five housekeeping genes identical to ST8, and tkt
gene identical to ST7, suggesting that ST11 is another recombi-
nant of ST7 and ST8 (Table 1). Thus, two oral strains (ST7 and
ST8) and three recombinant variants (ST9, ST10 and ST11) were
identified from patient 2 (Table 1).
The sequences of all six housekeeping genes of the 10 oral
isolates (P3UCO1-O10) of patient No. 3 were identical, suggesting
that this patient was colonized with a single oral C. concisus strain
(ST12) (Table 1).
One oral C. concisus isolate was available from each of the
remaining four patients (patients No. 5 to No. 8). The four
C. concisus isolates from these four patients differed at all six
housekeeping genes, each representing a different strain.
The nine isolates (H1O1-O9) obtained from the healthy
individual No. 1 had identical housekeeping genes, suggesting
that this individual was colonized with a single oral C. concisus
strain (ST15) (Table 1). One oral C. concisus isolate was available
from each of the remaining five healthy controls (H2-H6). Four of
these healthy controls were colonized with a different C. concisus
strain (differing at six housekeeping genes), except for H2O1 which
had atpA and tkt genes identical to C. concisus ST12 (Table 1).
MLST Analysis of Enteric C. Concisus Isolated from
Patients with IBD
The intestinal biopsy C. concisus isolate (P1CDB1(UNSWCD)) of
patient No. 1 (designated as ST6) had five unique housekeeping
genes (Table 1). However, its asd gene was identical to the patient’s
own oral ST1, ST3 and ST5, suggesting that ST6 has acquired its
asd gene from the patient’s own oral C. concisus isolates (Table 1).
The 10 intestinal biopsy C. concisus isolates (P3UCB1-B10)
obtained from patient No. 3 had six housekeeping genes identical
to that of the patient’s own oral C. concisus isolates, indicating that
the oral and intestinal biopsy C. concisus isolates are the same strain
(ST12) (Table 1). Two luminal-washout isolates (P3UCLW1 and
P3UCLW2) were obtained from patient No. 3. P3UCLW2 (ST13)
had five housekeeping genes identical to the patient’s own oral and
intestinal biopsy isolates (ST12) and differed only by one base in
pgi, suggesting that ST13 is a mutational variant of ST12 (Table 1).
P3UCLW1 (ST14) had six housekeeping genes that were different
from the patient’s own oral and intestinal biopsy C. concisus isolates,
representing a different C. concisus strain (Table 1).
Campylobacter concisus and IBD
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To further illustrate the genetic relationship between oral and
enteric C. concisus strains isolated from patients with IBD and
controls, a phylogenetic tree was constructed based on the
sequences of the six housekeeping genes analysed (Figure 1). The
housekeeping genes of the whole genome sequenced C. concisus
strain 13826 were also included.
C. concisus isolates obtained from the majority of the patients
with IBD (6/8) formed one cluster (Cluster 1). The C. concisus strain
(P1CDB1(UNSWCD)) isolated from intestinal biopsies of patient
No. 1 with CD, C. concisus strain 13826 (a strain isolated from fecal
sample of a patient with bloody diarrhea) and the oral C. concisus
isolate obtained from healthy individual No. 3 were also grouped
into Cluster 1. All enteric invasive Campylobacter concisus (EICC)
strains (see results in Table 2) were grouped into Cluster 1
(Figure 1). Seven of the eight individuals (7/8, 87.5%) whose
isolates belonged to Cluster 1 had inflammatory enteric diseases
(six patients with IBD and one had bloody diarrhea), which was
significantly higher than the remaining individuals (2/7, 28.6%)
(P,0.05). Among the C. concisus isolates that did not belong to
Cluster 1, six isolates were genetically closely related, forming a
second cluster (Cluster 2). The oral C. concisus isolate obtained from
a healthy control (H6O1) was genetically distinct from the other C.
concisus isolates (Figure 1).
The intestinal biopsy isolate of patient 1 (P1CDB1(UNSWCD))
was genetically most closely related to the oral C. concisus isolate of
a patient with CD (P6CDO1) (Figure 1). The intestinal biopsy
isolates of patient No. 3 (P3UCB1-B10) were identical to the
patient’s own oral isolates (P3UCO1-10). One luminal-washout
isolate (P3UCLW2) of patient No. 3 was very closely related to the
patient’s own oral and intestinal biopsy isolates. The second
luminal-washout C. concisus isolate (P3UCLW1) of this patient was
different from the patient oral and intestinal C. concisus isolates, but
was more closely related to the oral isolates of healthy control
No. 1 (Figure 1).
Comparison of Protein Profiles of Different C. Concisus
Isolates
All 70 C. concisus isolates analyzed by MLST were also subjected
to whole cell protein profile analysis. The protein profile types of
all 70 C. concisus isolates were shown in Figure 1 and the
representative protein profiles of C. concisus isolates from each
individual are shown in Figure 2. The 21 oral C. concisus isolates
(P1CDO1-O21) of patient 1 showed two different protein profiles
(P1-1 and P1-2). Thus, the different strains showed different
Table 1. Sequence types (ST) and allelic profiles of C. concisus isolated from patients with IBD and controls.
Isolate ID Total No. of isolate ST asd aspA atpA glnA pgi tkt
P1CDO1, P1CDO5-O12, P1CDO14-O17,
P1CDO19-O21
16 1 874611
P1CDO3, P1CDO18 2 2 253775
P1CDO4 1 3* 854612
P1CDO13 1 4* 174611
P1CDO2 1 5* 874612
P1CDB1(UNSWCD) 1 6 @ 842843
P2CDO1,P2CDO4 2 7 785587
P2CDO3,P2CDO7 2 8 666498
P2CDO5 1 9* 785588
P2CDO2 1 10* 686498
P2CDO6 1 11* 666497
P3UCO1-P3UCO10, P3UCB1-P3UCB10 20 12 511134
P3UCLW2 1 13 511124
P3UCLW1 1 14 428364
H1O1-H1O9 9 15 337256
H5O1 1 16 10 18 16 9 12 10
P5CDO1 1 17 11 14 14 14 10 17
H2O1 1 18 12 16 1 3 15 4
P6CDO1 1 19 13 9 15 13 19 9
H6O1 1 20 14 12 9 16 14 16
P8UCO1 1 21 15 17 13 12 18 15
P7UCO1 1 22 16 15 11 10 11 11
H3O1 1 23 17 13 12 11 17 13
P4CDO1 1 24 18 10 16 17 13 12
H4O1 1 25 9 1 11 01 51 61 4
C. concisus strain 13826 26 19 19 17 18 20 18
*Recombinant or mutational variants of the patient’s own oral C. concisus strains.
@This strain, which was isolated from a patient with CD, had asd gene identical to the patient’s own oral C. concisus isolates.
doi:10.1371/journal.pone.0038217.t001
Campylobacter concisus and IBD
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(see MLST data). The intestinal biopsy isolate
(P1CDB1(UNSWCD)) of patient No. 1 showed a protein profile
(P1-3) that was different from the patient’s oral strains. The seven
oral C. concisus isolates (P2CDO1-O7) from patient No. 2 revealed
two protein profiles (P2-1 and P2-2). Again, individual strains
showed different protein profiles, the recombinant variants did not
generate new protein profiles. The oral C. concisus isolates of
patient No. 3 (P3UCO1-O10) showed an identical protein profile
(P3-1), consistent with the finding that all oral C. concisus isolates of
this patient had identical sequences of housekeeping genes and
representing a single strain. The intestinal biopsy C. concisus isolates
(P3UCB1-B10) and one luminal-washout isolate of patient 3
(P3UCLW2) showed the same protein profile (P3-2), which was
identical to the protein pattern of the patient’s oral C. concisus
isolates except for the disappearance of a 210 kD band (band A in
Figure 2). The second luminal-washout C. concisus isolate
(P3UCLW1) showed a different protein profile (P3-3) (Figures 1
and 2).
Sequencing of the 210 kD band of P3UCO5 (oral isolate)
identified 47 C. concisus proteins, the majority of which were
ribosomal proteins and various proteins involved in metabolism.
Interestingly, one protein was a bacterial virulence protein S-layer-
RTX.
All oral C. concisus isolates of the healthy control No. 1 showed
an identical C. concisus protein profile (H1-1) (Figure 2), consistent
with the finding that all oral C. concisus isolates from this individual
had identical housekeeping genes.
The C. concisus isolates obtained from the remaining patients and
controls showed individual protein patterns (Figure 2).
Disease associated protein profiles were not identified.
Detection of Enteric Invasive C. Concisus (EICC) Oral
Strains in Patients with IBD
The invasiveness of all 70 C. concisus isolates to Caco2 cells
was examined and expressed as invasive index. EICC strains,
which have an invasive index $1, are shown in Table 2. EICC
oral strains were detected in 50% (4/8) patients with IBD and
none of the controls (0/6) (Table 2). However, the prevalence of
EICC oral strains in patients with IBD was not statistically
different from that in controls (P.0.05). The remaining
C. concisus isolates had an invasive index ,1. The positive
control invasive C. concisus strain (P1CDB1(UNSWCD)) showed
an invasion index of 1.3.
Identification of Bacterial Proteins that may be
Associated with C. Concisus Enteric Epithelial Invasion
Given that patient 1 was colonized with both EICC and non-
EICC oral C. concisus isolates, we sequenced the most abundantly
expressed protein band (band B shown in Figure 2) of an EICC
isolate (P1CDO3) and its corresponding band (band C shown in
Figure 2) of a non-EICC oral isolate (P1CDO2), attempting to
identify some bacterial proteins that may be associated with
C. concisus invasion to intestinal epithelial cells.
Twenty-three and 21 C. concisus proteins were identified from
the protein band of the EICC isolate and the non-EICC isolate
respectively. Seventeen proteins were common proteins identified
from both the EICC isolate and the non-EICC isolate, and these
proteins are involved in protein transport, metabolism and protein
synthesis. General glycosylation pathway protein and Type II
secretion system protein E, which were previously shown to be
associated with bacterial virulence, were identified only from the
protein band of EICC isolate. The distinctive proteins identified
from the EICC isolate and the non-EICC isolate are listed in
Table 3.
Bacterial Morphology of EICC and Non-EICC C. Concisus
Isolates
To observe whether EICC isolates and non-EICC isolates are
morphologically different, an EICC oral isolate (P1CDO3), a non-
EICC oral isolate (P1CDO2) and an EICC enteric isolate
(P1CDB1(UNSWCD)) were examined using electron microscopy.
Both EICC and non-EICC isolates showed a similar morphology.
Flagellum was present in all isolates (Figure 3).
Discussion
This study examined whether patients with IBD are colonized
with specific oral C. concisus strains and whether oral C. concisus
strains have enteric pathogenic potential. Furthermore, this study
Figure 1. Neighbour-Joining tree based on the sequences of six housekeeping genes (asd, aspA, atpA, glnA, pgi and tkt) illustrating
the phylogenetic relationships of oral and enteric Campylobacter concisus isolates analysed in this study. Isolates from patients with IBD
are coloured red. Isolates from a healthy control are coloured blue. Clusters are indicated in roman numerals. Campylobacter curvus is used as an
outgroup. Alongside the tree on the right are the MLST sequence types (ST) and protein profiles. Campylobacter concisus strain 13826 is the whole
genome sequenced strain (Accession No.: CP000792.1).
doi:10.1371/journal.pone.0038217.g001
Table 2. Enteric invasive C. concisus (EICC) oral isolates detected in patients with IBD.
Individual ID and Clinical condition Sample source EICC isolates identified
Invasion Index*
mean±SE
Patient No. 1, CD Saliva P1CDO3 P1CDO18 2.060.9 1.560.2
Patient No. 1, CD Intestinal biopsy P1CDB1 (UNSWCD)
# 1.360.2
Patient No. 2, CD Saliva P2CDO1 P2CDO2 P2CDO3 P2CDO4 P2CDO5
P2CDO6 P2CDO7
9.560.9 6.561.4 11.163.0
6.461.0 560.9 12.363.2
11.262.8
Patient No. 5, CD Saliva P5CDO1 4.061.1
Patient No. 8, UC Saliva P8UCO1 3.060.9
*The invasion index was the average of triplicate experiments
#Positive control strain used in this study.
doi:10.1371/journal.pone.0038217.t002
Campylobacter concisus and IBD
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given patient with IBD results from the endogenous colonization
of the patient’s own oral C. concisus strain.
MLST analysis revealed an association between Cluster I
C. concisus strains and enteric inflammatory diseases including IBD
(see results section). The oral C. concisus strains isolated from
patients with IBD were predominantly grouped into Cluster I
(Figure 1). EICC oral C. concisus strains were detected in 50% of
patients with IBD and none of the controls (Table 2). All EICC
oral C. concisus strains were in Cluster I. C. concisus colonizing
intestinal tissues of patients with IBD, at least in some instances,
originated from the colonization of the patients own oral C. concisus
strain (Figure 1 and Table 1). Taken together, these results suggest
that patients with IBD are colonized with a specific group of oral
C. concisus strains that have enteric pathogenic potential if
colonizing the intestinal tract.
Patient No. 1 was colonized with both EICC strain and non-
EICC oral strains, which were morphologically indistinguishable
(Figure 3). We attempted to identify proteins that may be
associated with C. concisus intestinal epithelial invasion by
sequencing the most abundantly expressed protein band of an
EICC isolate and its corresponding protein band of a non-
EICC isolate (Table 3 and Figure 2). Use of EICC and non-
EICC C. concisus strains isolated from the oral cavity of the same
individual would minimize the influence of environmental
factors on bacterial protein expressions. We found that two of
the proteins that were identified from the EICC isolate,
including general glycosylation pathway protein and type II
secretion system protein E, are particularly interesting in
relation to bacterial virulence.
General glycosylation system has been reported to be important
for C. jejuni to attach to and invade human epithelial cells [19]. The
Figure 2. Representative whole cell protein profiles of oral and enteric C. concisus isolates obtained from patients with IBD and
healthy controls. Arrows indicate protein bands that have been sequenced for protein identification. M: molecular weight Marker. Each lane was
labelled as Protein profile (Isolate ID).
doi:10.1371/journal.pone.0038217.g002
Table 3. Distinctive proteins identified from the most abundantly expressed protein band
# of an oral EICC isolate and the
corresponding band of a non-EICC oral C. concisus isolate obtained from patient 1.
EICC isolate (P1CDO3) Non-EICC isolate (P1CDO2)
General glycosylation pathway protein* Pyridoxal phosphate-dependent enzyme
Outer membrane protein Peptide chain release factor 2 Hypothetical protein
CCC13826_1624 Type II secretion system protein E*
3-isopropylmalate dehydratase large subunit Glutamate dehydrogenase Signal
recognition particle protein Threonine dehydratase
#Protein bands were shown in Figure 3.
*Proteins related to bacterial virulence.
doi:10.1371/journal.pone.0038217.t003
Campylobacter concisus and IBD
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components including T2SS protein E, is one of the five protein
secretion systems that Gram-negative bacteria use to export
proteins from within the bacterial cell to the extracellular
environment or into host cells [20,21]. T2SS has been shown to
be important in bacterial pathogenesis [22]. A study by Iwobi et al
showed that a novel type II secretion gene cluster is present only in
high-pathogenicity Yersinia enterocolitica strains [23]. In our study,
the fact that General glycosylation system protein and T2SS
protein E were identified only from the protein band of the EICC
isolate, not from the corresponding protein band of the non-EICC
isolate indicates a difference of these proteins in EICC and non-
EICC isolates. Future studies examining genes coding for these
proteins in EICC and non-EICC isolates will further illustrate
whether General glycosylation system and T2SS play a role in
C. concisus invasion to intestinal epithelial cells.
A recent study by Kaakoush et al detected exotoxin 9 gene
which is located in the plasmid in four enteric C. concisus strains
that were invasive to Caco2 cells including the UNSWCD strain
[24]. The presence of plasmid and the exotoxin 9 gene in oral
C. concisus strains isolated from patients with IBD and controls
should be examined in future studies. There are other evidence
supporting that specific oral C. concisus strains may be enteric
pathogenic. For example, Nielsen et al showed that both oral and
fecal C. concisus strains induced epithelial barrier dysfunction [13].
The oral cavity is the primary colonization site of C. concisus in
humans. Using a filtration method, we previously isolated
C. concisus from 75% of saliva samples collected from healthy
individuals and 85% of saliva collected from patients with IBD
[18]. In comparison to the human oral cavity, the human intestine
represents a less favourable environment for C. concisus growth.
Using the same filtration method, Engberg et al isolated C. concisus
from 2.8% of fecal samples collected from healthy individuals [25].
C. concisus requires H2-enriched microaerobic condition for growth
[3]. H2 in the human intestine is generated by bacterial
fermentation of unabsorbed carbohydrates; the amount of H2
available in an individual’s intestine is influenced by the ingested
food and the composition of the local intestinal microbial
community [26,27]. Thus, whether oral C. concisus strains are able
to establish intestinal colonization and multiply to a sufficient
number to cause enteric disorders will be determined by both the
properties of C. concisus strains and the local intestinal environ-
ment, the latter may fluctuate due to the change of ingested food
and the composition of an individual’s intestinal microbial
community.
Humans were previously considered as the only host of
C. concisus, however, recently C. concisus was detected in fecal and
saliva samples of domestic dogs and cats [28,29]. Whether
domestic pets are an additional source of human intestinal
C. concisus infection needs to be investigated. A study by Lynch
et al isolated C. concisus from chicken and beef meat [30]. While
chicken and beef meat may serve as a source of human infection, it
is unable to conclude whether chicken and cattle are a natural host
of C. concisus.
Oral and intestinal biopsy C. concisus isolates of patient 3
revealed identical protein profiles, except for the disappearance
of a 210 kD protein band in the intestinal biopsy C. concisus
isolates (Figure 2). Interestingly, S-layer-RTX protein was
identified from this 210 kD protein band of the oral isolate.
S-layer is a cell surface protein found in a range of bacterial
species. RTX proteins are a family of proteins secreted by a
variety of Gram-negative bacteria, which exhibit various
biological functions including formation of the S-layer protein
in some bacterial species [31]. S-layer contributes to bacterial
pathogenesis by adhering to host cells and immune evasion
[32]. Campylobacter fetus and Campylobacter rectus possess S-layer
[33]. High frequency antigenic variation of S-layer in C. fetus,
resulting from DNA inversion, has been reported [33,34].
Future studies are required to examine whether the disappear-
ance of S-layer-RTX protein in intestinal biopsy C. concisus
isolates in this patient is due to antigenic variation. S-layer
RTX protein was previously detected in the
P1CDB1(UNSWCD) strain [35]. Kalischuk et al reported that
the gene coding for S-layer RTX was detected in two C. concisus
strains isolated from fecal samples of healthy individuals, but not
in C. concisus strains isolated from fecal samples of patients with
diarrhea [15].
This study showed that the genome of C. concisus species is highly
diverse. All individuals included in this study were colonized with
different C. concisus strains, demonstrated by the findings that these
C. concisus isolates differed at all six housekeeping genes (except for
H2O1 strain, which had atpA and tkt genes identical to that of
ST12) and showed unique protein profiles. This is consistent with
the finding by Aabenhus et al [36]. Aabenhus et al examined 62
Figure 3. Electron Microscopic image of an oral EICC isolate, an oral non-EICC isolate and an enteric EICC isolate. All isolates were
cultured from Patient No. 1.
doi:10.1371/journal.pone.0038217.g003
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(AFLP) and found that all C. concisus strains gave unique AFLP
profiles [36]. Our finding that C. concisus strains undergo natural
recombination (Table 1) offer an explanation for the high genetic
diversity of C. concisus species, as observed by other research groups
[36,37,38,39].
From the luminal-washout of patient No. 3, two C. concisus
isolates were isolated. While one isolate (P3UCLW2) was the
variant of the C. concisus strain colonizing the intestinal tissues of
this patient, the other isolate (P3UCLW1) was a different strain
which was closely related to the oral C. concisus strain of healthy
control No. 1 (Figure 1 and Table 1). This suggests that C. concisus
detected in fecal samples may contain both C. concisus strains
colonizing the intestinal tissues and C. concisus strains transiently
colonizing the fecal materials.
In summary, this study provides the first evidence that patients
with IBD are colonized with a group of specific oral C. concisus
strains that may have enteric pathogenic potential. In addition,
this study showed that C. concisus colonizing intestinal tissues of
patients with IBD, at least in some instances, results from an
endogenous colonization of the patient’s own oral C. concisus and
that C. concisus strains undergo natural recombination.
Materials and Methods
Ethics Statement
Saliva samples were obtained at the Prince of Wales Hospital,
the St George Hospital and Sydney Children’s Hospital, Sydney,
Australia. Ethics approvals for this study were granted by the
Ethics Committees of the University of New South Wales and the
South East Sydney Area Healthy Service (Ethics Nos: HREC
09237/SESIAHS 09/078, HREC08335/SESIAHS(CHN)07/48
and HREC 06233/SESAHS (ES) 06/164). Written informed
consent was obtained from all subjects in this study.
C. Concisus Isolates and Cultivation
A total of 70 C. concisus isolates obtained from eight patients
with IBD and six controls were included in this study. Enteric
C. concisus refers to isolates cultured from intestinal biopsies or
luminal-washout fluid. Oral C. concisus refers to isolates cultured
from saliva. Luminal-washout fluid was the fluid collected from
luminal fluid draining tube prior to the start of the colonoscopy,
which contains fecal bacteria and the mucosa associated
bacteria flushed out from the intestinal mucus due to the
severe diarrhoea induced during the preparation for colonosco-
py. The enteric C. concisus isolate of patient 1 (P1CDB1) was
isolated by Zhang et al [9], which was named as UNSWCD in
a following study by Man et al [14]. To maintain the
consistency with the previous publications and the naming
system in this study, we used P1CDB1 (UNSWCD) to label this
strain in this study. The enteric C. concisus isolates of patient 3
were isolated by Mahendran et al [11]. The oral C. concisus
isolates were either isolated in our previous studies or in this
study [18]. The identities of these C. concisus isolates were
confirmed by microscopic examination of bacterial morphology
and C. concisus specific PCR [12]. Details of the C. concisus
isolates used in this study are listed in Table 4.
C. concisus isolates were cultured on Horse blood agar (HBA),
prepared using Blood Agar Base No. 2 supplemented with 6% (v/
v) defribinated horse blood and 10 mg/ml vancomycin (Oxoid
Australia Pty Limited, South Australia). Culture plates were
incubated at 37uC for 48 hours under microaerobic conditions
generated using a Campylobacter gas generating kit (Oxoid).
The clinical information of patients included in this study is
shown in Table 5.
Bacterial DNA Extraction
C. concisus DNA was extracted using the Puregene DNA
Extraction kit (Gentra, Minneapolis, USA) following the manu-
facturer’s instructions.
Comparison of the Sequences of Housekeeping Genes of
Oral and Enteric C. Concisus Isolates by Multilocus
Sequence Typing
Choice of housekeeping genes and primer design. Six
housekeeping genes (aspA, glnA, tkt, asd, atpA and pgi) were selected
for MLST analysis. These housekeeping genes have previously
been used for MLST analysis of C. jejuni [40,41,42].
The polymerase chain reaction (PCR) primers used to amplify
each of the above genes were designed using the software Primer 3
plus, based on the genome sequence of C. concisus strain 13826
(Accession No. CP000792.1). The sequences of the PCR primers
used are shown in Table 6.
Amplification and sequencing of MLST genes. To
amplify the MLST genes, hot start PCR reactions were
performed in a 25 ml reaction mixture containing 16 PCR
buffer, 200 nM of deoxynucleotide triphosphate, 2.5 mM
MgCl2, 5.5 U of Taq polymerase (Fisher Biotech, Subiaco,
Australia), 10 pmol of each primer and 10 ng of bacterial DNA
extracted from each C. concisus isolates. The thermal cycling
conditions consist of denaturing at 96uC for 2 minutes, followed
by 40 cycles of 94uC for 10 seconds, annealing for 10 seconds
and 72uC for 45 seconds. The annealing temperatures were
55uC for aspA and atpA,5 1 uC for tkt and asd. The annealing
temperatures for gln and pgi were 55uC–57uC, depending on
individual isolates. Both strands of all PCR products were
sequenced using BigDye
TM terminator chemistry (Applied
Biosystems, Foster City, CA) and separated on an ABI Capillary
DNA Sequencer ABI3730 (Applied Biosystems).
MLST analysis. Sequences of housekeeping genes of C. con-
cisus isolates were aligned and compared using software programs
of MEGA 4 [43] and an in-house script MULTICOMP [44].
PHYLIP was used to generate neighbour-joining trees [45].
Campylobacter curvus (Accession No. CP000767.1) was used as an
outgroup.
For each housekeeping gene, the different sequences present in
different isolates were assigned distinct allele numbers. The allele
numbers at each of the housekeeping genes defined the allelic
profiles. Each isolate with a distinct allelic profile was referred as
an individual sequence type (ST). Isolates with identical sequences
at all six housekeeping genes were defined as the same strain.
Isolates with different sequences at all six housekeeping genes were
defined as different strains. In the case that a given individual was
colonized with multiple C. concisus strains (more than one C. concisus
strain), if evidence suggesting that some C. concisus isolates were
generated due to gene recombination or mutations of the
C. concisus strains colonizing the same individual, the generated
C. concisus isolates were defined as recombinant or mutational
variants.
GenBank Sequence Submission
Sequences of housekeeping genes amplified by PCR were
submitted to GenBank. The accession numbers of the sequences of
the PCR products of housekeeping genes submitted to GenBank
were JQ683402-JQ683505.
Campylobacter concisus and IBD
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e38217Comparison of Whole Cell Protein Profiles of Oral and
Enteric C. Concisus Isolates
Whole cell proteins of C. concisus isolates were prepared.
Briefly, C. concisus was harvested from HBA plates following
cultivation for two days. After washing three times with PBS,
the pellet was frozen-thawed three times using liquid nitrogen,
then suspended in 600 ml of PBS. The bacterial mixtures were
sonicated on ice for 3 minutes with 0.5 seconds intervals (40%
amplitudes). The protein concentrations were determined using
the BCA
TM protein assay kit (Pierce, Rockford, USA). 15 mg
whole cell proteins of each isolate were loaded on to 12%
sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) to examine the whole cell protein profiles as
described previously [46].
Investigation of Enteric Invasiveness of C. Concisus
Isolates
Invasive abilities of C. concisus isolates to Caco2 cells were
examined using previously described gentamicin protection assay
with modifications [14,47,48].
Briefly, Minimum Essential Medium (MEM) supplemented with
10% heat inactivated fetal bovine serum (HI-FBS), 1 mM Sodium
Table 4. C. concisus isolates used in this study.
Isolate ID Number of isolates
# Sample source* Individual ID and diagnosis
P1CDO1-P1CDO21 21 Saliva Patient No. 1, CD
P1CDB1(UNSWCD) 1 Intestinal biopsies Patient No. 1, CD
P2CDO1-P2CDO7 7 Saliva Patient No. 2, CD
P3UCO1-P3UCO10 10 Saliva Patient No. 3, UC
P3UCB1-P3UCB10 10 Intestinal biopsies Patient No. 3, UC
P3UCLW1-P3UCLW2 2 Luminal-washout fluid Patient No. 3, UC
P4CDO1 1 Saliva Patient No. 4, CD
P5UCO1 1 Saliva Patient No. 5, UC
P6CDO1 1 Saliva Patient No. 6, CD
P7UCO1 1 Saliva Patient No. 7, UC
P8UCO1 1 Saliva Patient No. 8, UC
H1O1-H1O9 9 Saliva Healthy individual No. 1
H2O1 1 Saliva Healthy individual No. 2
H3O1 1 Saliva Healthy individual No. 3
H4O1 1 Saliva Healthy individual No. 4
H5O1 1 Saliva Healthy individual No. 5
H6O1 1 Saliva Healthy individual No. 6
#A total of 70 C. concisus isolates were examined in this study.
*C. concisus isolated from intestinal biopsies and luminal-washout fluid was referred as enteric C. concisus and C. concisus isolated from saliva was referred as oral C.
concisus.
doi:10.1371/journal.pone.0038217.t004
Table 5. Clinical information of patients included in this study.
Patient ID-Sex- Age at diagnosis*
Diagnosis and disease activity at the time
of sample collection Montreal classification [50,51,52]
Patient No. 1-F-2y CD, new case, active L2, L4
Patient No. 2-M-19y CD, relapse, active L3, L4
Patient No. 3-M-23y UC, new case, active Extensive E3/S1
Patient No. 4-M-16y CD, remission L3,L4
Patient No. 5-M-13y CD, remission L2,L4
Patient No. 6-M-13y CD, remission L3, L4
Patient No. 7-M-65y UC, new case, active Left sided E2/S2
Patient No. 8-M-16y UC, remission Left sided E2/S1
*C. concisus strains were previously isolated from biopsies of patients No. 1 and No. 3 [9,11]. The intestinal biopsies collected from patients No. 1 and No. 3 were from
caecum and descending colon respectively, sampled from areas next to inflamed mucosa. C. concisus was detected in intestinal biopsies collected from patients No. 2
and No. 7 by PCR [11]. No intestinal biopsies were available from patients in remission.
Patients No. 2, No. 5, No. 6 and No. 8 were being treated with anti-inflammatory drugs (infliximab, aminosalicylates, methotrexate or azathioprine) at the time of saliva
collection. Patient No. 4 had ileocolonic resection and antibiotics treatment (metronidazone and ciprofloxacin) two years ago. None of the patients were receiving
antibiotics treatment at the time of sample collection for this study.
doi:10.1371/journal.pone.0038217.t005
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icillin, 100 mg/ml streptomycin and 225 mg/l Sodium Bicarbon-
ate (Invitrogen Australia Pty Limited, Mulgrave, Australia) was
used for routine maintenance of Caco2 cells. For gentamicin
protection assay, Caco-2 cells (5610
5 cells/well) were seeded onto
24-well cell culture plates pre-treated with rat tail collagen type 1
(0.05 mg/ml) (BD Australia, North Ryde, Australia) and incubat-
ed at 37uC with 5% CO2 for 4 days to form a monolayer. The
monolayer was washed 4 times using Phosphate Buffer Saline
(PBS) and incubated with C. concisus isolates at a multiplicity of
infection (MOI) of 100 for 2 hours in MEM media containing no
antibiotics. Six wells of Caco2 cells were infected with each
C. concisus isolate. Following the 2 hour incubation, the wells were
washed 4 times with PBS. The Caco2 monolayer of three wells
was lysed with 1% Triton X-100 for 5 minutes. Serial dilutions of
cell lysates were inoculated onto HBA plates and incubated as
described above. Colony-forming units (CFU) of C. concisus were
recorded, which were regarded as the numbers of C. concisus that
have adhered to Caco2 cells. The remaining three wells of Caco2
cells infected with C. concisus were incubated with 1 ml of MEM
containing 200 mg/ml of gentamicin to kill the extracellular
bacteria. Following washing of the Caco2 monolayer for 5 times
using PBS, the cells were lysed with 1% Triton X-100. Serial
dilutions of cell lysates were inoculated onto HBA plates and
incubated for two days. CFU of C. concisus were recorded, which
were regarded as the numbers of C. concisus that have been
internalised into Caco2. Gentamicin assay was repeated three
times.
Invasive index, which is the number of internalized C. concisus/
number of adherent C. concisus 6 100, was calculated using the
formula described by Larson et al [49]. A C. concisus strain that has
an invasive index $1 was defined as an enteric-invasive C. concisus
(EICC) strain. This definition was based on previous studies
showing that the established human enteric pathogen Campylobacter
jejuni with an invasive index $1 causes symptoms in infected pigs
similar to human symptoms [49]. The UNSWCD strain, which
was previously shown to invasive to Caco2 cells [14), was used as
the positive control.
Mass Spectrometry Analysis
A number of C. concisus protein bands separated on SDS-PAGE
were subjected to mass spectrometry analysis to identify proteins
that may be important for C. concisus invasion to Caco2 cells and
for C. concisus intestinal colonization. Briefly, protein bands of
interest were excised from Commassie Blue stained polyacryl-
amide gel and were digested with trypsin. Digested peptides were
separated by nano-liquid chromatography (LC) using an Ultimate
3000 HPLC and autosampler system (Dionex, Amsterdam, The
Netherlands) and then subjected to analysis using a LTQ-FT Ultra
mass spectrometer (Thermo Electron, Bremen, Germany). All
MS/MS spectra were searched against NCBI database using
MASCOT (version 2.3). Mass spectrometric analysis was carried
out at the Bioanalytical Mass Spectrometry Facility, University of
New South Wales, Australia.
Scanning Electron Microscopy
Scanning electron microscopy was used to examine the
morphology of two different oral C. concisus isolates, one shown
to have an invasive index .1 (defined as EICC in this study) and
another shown to have an invasive index ,1 (defined as non-
EICC in this study). C. concisus suspension prepared using MEM
containing 10% HI-FBS was placed on glass cover slips. The glass
cover slips were incubated at 37uC with 5% CO2 for 2 hours, the
bacteria were fixed with 2% glutaraldehyde and 2.5% paraforma-
dehyde in 0.1 mol/L phosphate buffer (pH 7.4). Following
dehydration in ethanol and critical point drying, C. concisus was
mounted on carbon tabs, gold-coated then observed using
Nova
TM NanoSEM 230 high resolution scanning electron
microscope (FEI, Oregon, USA). Scanning electron microscopic
examination was performed at the Electron Microscope Unit at
the University of New South Wales, Australia.
Statistic Analysis
Fisher’s exact test (two tailed) was used in this study. Statistical
analysis was performed using GraphPad Prism 5 software (San
Diego, CA).
Supporting Information
Figure S1 The polymorphic nucleotides of MLST genes
and Sequence types (ST) of C. concisus isolates. Six
housekeeping genes (asd, aspA, atpA, glnA, pgi and tkt) of 70 oral and
enteric C. concisus isolates cultured from eight patients with IBD
and six healthy control were analysed. Dot indicates that the base
is the same as the consensus. *The whole genome sequenced
Campylobacter concisus strain 13826 (Accession No.: CP000792.1).
(DOCX)
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